These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36077195)

  • 1. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.
    Yui K; Imataka G; Yoshihara S
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism.
    Nadeem A; Ahmad SF; Bakheet SA; Al-Harbi NO; Al-Ayadhi LY; Attia SM; Zoheir KMA
    Brain Behav Immun; 2017 Mar; 61():146-154. PubMed ID: 28034626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.
    Gozal E; Jagadapillai R; Cai J; Barnes GN
    J Neurochem; 2021 Oct; 159(1):15-28. PubMed ID: 34169527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox signaling in the gastrointestinal tract.
    Pérez S; Taléns-Visconti R; Rius-Pérez S; Finamor I; Sastre J
    Free Radic Biol Med; 2017 Mar; 104():75-103. PubMed ID: 28062361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of gene expression in the cyclooxygenase knockout mice - a connection to autism spectrum disorder.
    Rai-Bhogal R; Ahmad E; Li H; Crawford DA
    Eur J Neurosci; 2018 Mar; 47(6):750-766. PubMed ID: 29161772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets.
    Baranova J; Dragunas G; Botellho MCS; Ayub ALP; Bueno-Alves R; Alencar RR; Papaiz DD; Sogayar MC; Ulrich H; Correa RG
    Cell Mol Neurobiol; 2021 May; 41(4):619-649. PubMed ID: 32468442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the endocannabinoid system in neurological disorders.
    Zou M; Li D; Li L; Wu L; Sun C
    Int J Dev Neurosci; 2019 Aug; 76():95-102. PubMed ID: 30858029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Epigenetics and Redox Signaling in the Gut-Brain Communication and the Case of Autism Spectrum Disorder.
    Doenyas C
    Cell Mol Neurobiol; 2022 Mar; 42(2):483-487. PubMed ID: 34773541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of glutathione metabolism in autism spectrum disorder.
    Bjørklund G; Doşa MD; Maes M; Dadar M; Frye RE; Peana M; Chirumbolo S
    Pharmacol Res; 2021 Apr; 166():105437. PubMed ID: 33493659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Hexacyanoferrate (III) Nanocatalyst Enables Redox Homeostasis for Autism Spectrum Disorder Treatment.
    Feng S; Gong Y; Xia L; Lang Y; Shen Y; Li H; Feng W; Chen F; Chen Y
    Adv Mater; 2024 Sep; 36(39):e2405655. PubMed ID: 39096109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders.
    Pangrazzi L; Balasco L; Bozzi Y
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
    Kumar S; Reynolds K; Ji Y; Gu R; Rai S; Zhou CJ
    J Neurodev Disord; 2019 Jun; 11(1):10. PubMed ID: 31202261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of glutathione redox imbalance in autism spectrum disorder: A review.
    Bjørklund G; Tinkov AA; Hosnedlová B; Kizek R; Ajsuvakova OP; Chirumbolo S; Skalnaya MG; Peana M; Dadar M; El-Ansary A; Qasem H; Adams JB; Aaseth J; Skalny AV
    Free Radic Biol Med; 2020 Nov; 160():149-162. PubMed ID: 32745763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
    Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
    Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
    Vallée A; Vallée JN; Lecarpentier Y
    Mol Psychiatry; 2019 May; 24(5):643-652. PubMed ID: 30104725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warburg effect hypothesis in autism Spectrum disorders.
    Vallée A; Vallée JN
    Mol Brain; 2018 Jan; 11(1):1. PubMed ID: 29301575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress in Autism Spectrum Disorder.
    Bjørklund G; Meguid NA; El-Bana MA; Tinkov AA; Saad K; Dadar M; Hemimi M; Skalny AV; Hosnedlová B; Kizek R; Osredkar J; Urbina MA; Fabjan T; El-Houfey AA; Kałużna-Czaplińska J; Gątarek P; Chirumbolo S
    Mol Neurobiol; 2020 May; 57(5):2314-2332. PubMed ID: 32026227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: Role of IL-17A receptor signaling.
    Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Bakheet SA; Al-Harbi NO
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():204-211. PubMed ID: 30529000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases.
    Fang J; Sheng R; Qin ZH
    Antioxid Redox Signal; 2021 Oct; 35(12):951-973. PubMed ID: 34293949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.